Share This Article:

Survival and Prognostic Factors in Patients with Carcinoma of Cervical Stump

Abstract Full-Text HTML XML Download Download as PDF (Size:275KB) PP. 1008-1012
DOI: 10.4236/jct.2015.611109    2,706 Downloads   3,026 Views   Citations

ABSTRACT

Purpose: To evaluate patients with carcinoma of cervical stump (CCS) and analyse different clinico-pathologic factors affect prognosis. Patients and Methods: This study was carried out through review of clinical records of patients. Recorded data included information on age, tumor stage, presenting symptoms, size of tumor, histopathology, grade, type, cause of subtotal hysterectomy (STH), treatment and follow-up results. Staging according to International Federation of Gynecology and Obstetrics (FIGO) staging system was done through: PHYSICAL examination, pelvic examination under anaesthesia, chest X-ray, magnetic resonance imaging (MRI) of the abdomen and pelvis, cystoscopy, rectosigmoidoscopy and intravenous pyelography. Prognostic factors as age, size of tumor, stage, lymph node (LN) involvement, pathological type, grade and type of CCS either true or coincidental were analysed through multivariate analysis. Results: 62% of patients are above 50 years with stage II in 48.7%. Squamous cell carcinoma was more common but 54% are of GIII. 89% were true CCS. Positive lymph nodes were reported in 27%. The predominant reason for STH was abnormal bleeding (73%). In about 95% of cases, women seeked medical attention because of symptoms and the most common presenting symptom was bleeding (54%). According to the stage and performance status of patients, treatment consisted of radiotherapy either external or interstitial, chemotherapy and chemoradiotherapy. Through multivariate analysis, the following was found to have adverse impact on survival: Coincidental type (P = 0.04), high grade (P = 0.03), advanced stage (P = 0.01), larger tumor size (P = 0.02), lymph node involvement (P = 0.029) and older age (P = 0.035). While pathological type was not (P = 0.52). After median follow-up of 52 months; 5-year overall survival was 65%. Conclusion: CCS has a low morbidity. Adverse survival outcomes can be anticipated in those patients with: high grade lesions, advanced stages, large tumor size, coincidental type, older age and positive lymph node involvement.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Wahba, H. , El-Hadaad, H. , Abozeed, W. , Elnahas, W. , Roshdy, S. and Gamal, A. (2015) Survival and Prognostic Factors in Patients with Carcinoma of Cervical Stump. Journal of Cancer Therapy, 6, 1008-1012. doi: 10.4236/jct.2015.611109.

References

[1] Hasson, H.M. (1993) Cervical Removal at Hysterectomy for Benign Disease, Risk and Benefits. The Journal of Reproductive Medicine, 38, 781-790.
[2] Thakar, R., Ayers, S., Clarkson, P., Stanton, S. and Manyonda, I. (2002) Outcome after Total versus Subtotal Abdominal Hysterectomy. The New England Journal of Medicine, 347, 1318-1325.
http://dx.doi.org/10.1056/NEJMoa013336
[3] Learman, L.A., Summitt Jr., R.L., Varner, R.E., McNeeley, S.G., Goodman-Gruen, D., Richter, H.E., et al. (2003) Total or Supracervical Hysterectomy (TOSH) Research Group. A Randomized Comparison of Total or Supracervical Hysterectomy: Surgical Complications and Clinical Outcomes. Obstetrics & Gynecology, 102, 453-462.
http://dx.doi.org/10.1016/S0029-7844(03)00664-1
[4] Gimbel, H., Zobbe, V., Andersen, B.M., Filtenborg, T., Gluud, C., et al. (2003) Randomised Controlled Trial of Total Compared with Subtotal Hysterectomy with One-Year Follow-Up Results. BJOG, 110, 1088-1098.
http://dx.doi.org/10.1111/j.1471-0528.2003.02395.x
[5] Roovers, J.P., van der Bom, J.G., van der Vaart, C.H. and Heintz, A.P. (2003) Hysterectomy and Sexual Wellbeing: Prospective Observational Study of vaginal Hysterectomy, Subtotal Abdominal Hysterectomy, and Total Abdominal Hysterectomy. BMJ, 327, 774-778.
http://dx.doi.org/10.1136/bmj.327.7418.774
[6] El-Toukhy, T.A., Hefni, M., Davies, A. and Mahadevan, S. (2004) The Effect of Different Types of Hysterectomy on Urinary and Sexual Function: A Prospective Study. Journal of Obstetrics and Gynaecology, 24, 420-425.
http://dx.doi.org/10.1080/01443610410001685574
[7] Pecorelli, S., Zigliani, L. and Odicino, F. (2009) Revised FIGOs Staging for Carcinoma of the Cervix. International Journal of Gynecology & Obstetrics, 105, 107-108.
http://dx.doi.org/10.1016/j.ijgo.2009.02.009
[8] Pricop, M., Cocos, M., Aursulesei, D., Strat, L., Gafencu, C. and Bendescu, M. (1999) Cancer of the Cervical Stump. Rev Med Chir Soc Med Nat lasi, 103, 161-162.
[9] Hellstrom, A.C., Sigurjonson, T. and Pettersson, F. (2001) Carcinoma of the Cervical Stump. The Radiumhemmet Series1959-1987. Treatment and Prognosis. A Case Control Study. Acta Obstetricia et Gynecologica Scandinavica, 80, 152-157.
[10] Pettersson, F. (1998) Secondary Prevention. Screening for Carcinoma of the Cervix. In: Kavanagh, J.J., et al., Eds., Cancer in Women, Blackwell Science, Oxford, 240-250.
[11] Hellstrom, A.C., Hellman, K., Pettersson, B.F. and Andersson, S. (2011) Carcinoma of the Cervical Stump: Fifty Years of Experience. Oncology Reports, 25, 1651-1654.
[12] Igboeli, P., Kapp, D.S., Lawrence, R. and Schwartz, P.E. (1983) Carcinoma of the Cervical Stump: Comparison of Radation Therapy Factors, Survival and Patterns of Failure with Carcinoma of the Intact Uterus. International Journal of Radiation Oncology*Biology*Physics, 9, 153-159.
http://dx.doi.org/10.1016/0360-3016(83)90092-5
[13] Hannoun-Lévi, J.M., Peiffert, D., Hoffstetter, S., Luporsi, E., Bey, P. and Pernot, M. (1997) Carcinoma of the Cervical Stump: Retrospective Analysis of 77 Cases. Radiotherapy & Oncology, 43, 147-153.
http://dx.doi.org/10.1016/s0167-8140(97)01918-x
[14] Petersen, L.K., Mamsen, A. and Jakobsen, A. (1992) Carcinoma of the Cervical Stump. Gynecologic Oncology, 46, 199-202.
http://dx.doi.org/10.1016/0090-8258(92)90255-h
[15] Gibbons, S.K. and Keys, H.M. (1996) Special Situations in the Management of Early Cervical Cancer. In: Rubin, S.C., Hoskins, W.J., Eds., Cervical Cancer and Preinvasive Neoplasia, Lippincott-Raven, Philadelphia, 259-260.
[16] Goodman, H.M., Niloff, J.M., Buttlar, C.A., Welch, W.R., Marck, A., Feuer, E.J., et al. (1989) Adenocarcinoma of the Cervical Stump. Gynecologic Oncology, 35, 188-192.
http://dx.doi.org/10.1016/0090-8258(89)90041-3
[17] Miller, B.E., Copeland, L.J., Hamberger, A.D., Gershenson, D.M., Saul, P.B., Herson, J., et al. (1984) Carcinoma of the Cervical Stump. Gynecologic Oncology, 18, 100-108.
http://dx.doi.org/10.1016/0090-8258(84)90012-x
[18] Barillot, I., Horiot, J.C., Cuisenier, J., Pigneux, J., Schraub, S., Rozan, R., et al. (1993) Carcinoma of the Cervical Stump: A Review of 213 Cases. European Journal of Cancer, 39, 1231-1236.
http://dx.doi.org/10.1016/0959-8049(93)90063-L
[19] Kovalic, J.J., Grigsby, P.W., Perez, C.A. and Lockett, M.A. (1991) Cervical Stump Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 20, 933-938.
http://dx.doi.org/10.1016/0360-3016(91)90188-a
[20] Calais, G., Leloup, R., Chauvet, B., Body, G., Lansac, J., Bougnoux, P., et al. (1989) Carcinoma of the Cervical Stump. Retrospective Analysis of 43 Cases. Bull Cancer, 76, 1103-1110.
[21] Porpora, M.G., Nobili, F., Pietrangeli, D. and Falqui, L. (1991) Cervical Stump Carcinoma Therapy. European Journal of Obstetrics and Gynecology, 12, 45-50.
[22] Chen, L., Xia, T., Yang, Z. and Zhu, J. (2009) Comprehensive Treatment and Prognostic Factors in Patients with Carcinoma of the Cervical Stump. Clinical Oncology and Cancer Research, 6, 426-429.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.